GlassScriptPhysician profile
Rania Abdallah
NPI 1619105434
$1,757.17
in general payments reported to CMS, 2019-2025
11 companies · $394 in 2025
The $394 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $491 · 2022: $298 · 2023: $211 · 2024: $363 · 2025: $394.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $968.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $967.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $619.99 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $274.21 | 2022-2025 | Fasenra, Airsupra |
| United Therapeutics Corporation | $269.51 | 2024-2025 | Tyvaso |
| Regeneron Healthcare Solutions, INC. | $265.72 | 2024-2025 | Dupixent |
| Baxter Healthcare | $192.73 | 2022-2023 | Hillrom - Vest System Model 105 Home Care |
| Merck Sharp & Dohme LLC | $35.69 | 2023 | Keytruda |
| Genentech USA, INC. | $29.25 | 2022-2024 | Xolair |
| Phadia US INC. | $21.40 | 2023 | Immunocap |
| Grifols USA, LLC | $17.57 | 2023 | Prolastin-C Liquid |
| Genzyme Corporation | $17.14 | 2024 | |
| Harmony Biosciences LLC | $13.96 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rania Abdallah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.